QMB

Quality Means Business, Inc. (QMB) is a Boston, Massachusetts-based software company operating in AI-driven MedTech SaaS. Its flagship product, QualiVerse®, is described as a regulatory intelligence engine for medical device innovators, unifying design control, risk management, regulatory intelligence and compliance scoring within a single enterprise system. The platform converts standards such as ISO 13485, ISO 14971, IEC 62304 and EU MDR into workflow-aware processes intended to support compliance, product development and market entry.

According to the company, QualiVerse analyzes a product, identifies the applicable regulatory path, flags risks and generates FDA-ready documentation, with an "expert-in-the-loop" model providing human review of submissions. QMB positions itself as a vertical SaaS platform augmented by embedded expert services, targeting quality/regulatory affairs teams and new product development groups. The company also publishes a podcast, Quality in the Boardroom, and maintains sites at QMB.ai and QualiVerse.com.

QMB was founded and is led by Michel E. Moravia, Chairman & CEO, who is described as having 15+ years in MedTech regulatory and quality plus enterprise SaaS product experience at ETQ Reliance and ComplianceQuest and dual master's degrees from Boston University. Other leaders listed include Thaina C. Roman (COO & Co-Founder), Julian Weinstock (CTO), Christopher J. Wallace (CISO & Co-Founder), Leonard Glatkowski (EVP Regulatory & Customer Success), Aaron Dickens (VP of Sales), Scott McDermott (Chief of Staff), Elizabeth RedCloud (Director of Marketing) and Nirav Soni (Head of Quality Assurance, Client Engagement). The board includes Michel Moravia as Chairman, Orlando Watkins of The Boston Foundation and Robert Bennett, with Shannon Bean of CEI Ventures as board observer; an advisory board covers regulatory affairs, SaaS product and MedTech commercial expertise.